Actively Recruiting
Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor
Led by Ziekenhuis Oost-Limburg · Updated on 2026-02-24
30
Participants Needed
1
Research Sites
33 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.
CONDITIONS
Official Title
Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide signed and dated informed consent
- Adults older than 18 years of age
- Speak and understand the Dutch language
- Hospitalized for at least another 24 hours
You will not qualify if you...
- Life expectancy is less than 30 days
- Patient is isolated due to infection control
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ziekenhuis Oost-Limburg
Genk, Belgium, 3600
Actively Recruiting
Research Team
R
Ruben Knevels, MSc
CONTACT
F
Femke Wouters, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here